Skip to main content
# Title Department Research Year
1 Structure Based Design of Novel Azine Linked Hybrids of 2-Indolinone- Thiazolodine Scaffold as Potential Quorum Sensing Inhibitors for Fighting Antimicrobial Resistance Department of Medicinal Chemistry 2022
2 The inhibitory coreceptor CD22 restores B cell signaling by developmentally regulating Cd45 −/− immunodeficient B cells Department of Pharmaceutical Organic Chemistry 2022
3 Exploration of components contributing to potent cytotoxicity of Gardenia thunbergia L. f. against human leukemia and hepatoma Department of Pharmacognosy 2022
4 Evaluation of Different Surface Coating Agents for Selenium Nanoparticles: Enhanced Anti-Inflammatory Activity and Drug Loading Capacity Department of Pharmaceutics 2022
5 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Department of Pharmaceutics 2022
6 New Cell Cycle Checkpoint Pathways Regulators with 2-Oxo-indoline Scaffold as Potential Anticancer Agents: Design, Synthesis, Biological Activities and In Silico Studies Department of Medicinal Chemistry 2022
7 Selective Cytotoxic Constituents from Gardenia latifolia and Their In Silico Topoisomerase IIα Inhibition Department of Pharmacognosy 2022
8 Design and optimization of metformin hydrophobic ion pairs for efcient encapsulation in polymeric drug carriers Department of Pharmaceutics 2022
9 Graphene oxide modified glassy carbon electrode for determination of inagliptin in dosage form, biological fluids, and rats’ feces using square wave voltammetry Department of Pharmaceutical Analytical Chemistry 2022
10 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Pharmaceutics 2022